News
Financial burden on older adults with advanced cancer worsens quality of life
Among older adults with advanced cancer, those judged to have financial issues experience worse quality of life, with the adverse effects including higher levels of depression, anxiety and distress. The…
Integrated imaging opens the way for virtual biopsies
Combining computed tomography (CT) scans, spatial radiomic maps, and ultrasound (US) images creates a visual guide that helps doctors perform fewer and more accurate tumour biopsies. The feasibility study, published…
Cancer survivors at greater risk of subsequent primary cancers
Survivors of adult-onset cancers run a greater risk of developing and dying from subsequent primary cancers (SPCs) than the general population. The retrospective cohort study, reported in JAMA (December 22),…
Immunotherapy cardiotoxicity higher than previously estimated
Cancer patients receiving immunotherapy drugs have a much higher incidence of cardiac events than previous estimates from pharmacovigilance data, reports a nationwide Danish registry. The study, published in the European…
NHS England’s pilot of cancer screening blood test raises questions
The UK National Health Service (NHS) announced on the 27 November that it would be piloting an early detection multi-cancer blood test next year. This represents an important advance because…
Building back cancer services after Covid-19: European Cancer Organisation plan
The European Cancer Organisation has proposed seven urgent recommendations to ‘build back cancer services better’ after the ongoing challenges resulting from the Covid-19 pandemic. ‘The Impact of COVID-19 on Cancer…
Prolonged ADT use in prostate cancer increases CV mortality: A need for cardiovascular protection
Prolonged androgen deprivation therapy (ADT) exposure was found to be associated with reduced cardiorespiratory fitness (CRF) and increased cardiovascular (CV) mortality. The study, published in JACC: CardioOncology, emphasizes the need…
Serious patient-reported outcomes data gap in immunotherapy trials revealed
A review of trials of immunotherapy agents revealed a ‘considerable gap’ in the use of patient reported outcomes (PROs), reports a recent study. The data analysis study found PROs were…
Machine learning mortality predictions boost end-of-life conversations
A study of the use of machine learning to predict the risk of dying within six months, combined with behavioural nudges, led to increased serious illness conversations between oncologists and…
Two studies provide ‘building blocks’ for future advances in pancreatic cancer
Two recently published studies have provided insights into new ways of tackling pancreatic ductal adenocarcinomas (PDACs), a cancer where survival outcomes have made little progress in the past few decades.…